Takahashi, Naoto

University Health Network · Seoul National University · Chinese Academy of Medical Sciences & Peking Union Medical College · Seoul National University Hospital · University of Chicago · Jena University Hospital · Institute of Hematology & Blood Diseases Hospital · State Key Laboratory of Experimental Hematology · Eulji University Uijeongbu Eulji Medical Center · The University of Adelaide · Charité – Universitätsmedizin Berlin

5 papers on CoChatORCID 0000-0002-6758-3787

Most cited papers

Verified
A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer
Ng, K. P., Hillmer, A. M., Chuah, C. T. H., Juan, W. C., Ko, T. K., Teo, A. S. M., Ariyaratne, P. N., Takahashi, N., Sawada, K., Fei, Y., et al. (2012) · Nature Medicine
Cell death mechanisms and regulationLung Cancer Treatments and Mutations
Cited by 557
Verified
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
Hochhaus, A., Wang, J., Kim, D.-W., Kim, D. D. H., Mayer, J., Goh, Y.-T., le Coutre, P., Takahashi, N., Kim, I., Etienne, G., et al. (2024) · New England Journal of Medicine
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 171
Verified
Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Ohmachi, K., Niitsu, N., Uchida, T., Kim, S. J., Ando, K., Takahashi, N., Takahashi, N., Uike, N., Eom, H. S., Chae, Y. S., et al. (2013) · Journal of Clinical Oncology
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 171
Verified
Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
Tanaka, A., Nishikawa, H., Noguchi, S., Sugiyama, D., Morikawa, H., Takeuchi, Y., Ha, D., Shigeta, N., Kitawaki, T., Maeda, Y., et al. (2020) · Journal of Experimental Medicine
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 96
Verified
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
Matsumura, I., Ohtake, S., Atsuta, Y., Kurata, M., Minami, Y., Takahashi, N., Nakaseko, C., Iriyama, N., Fujimaki, K., Kakihana, K., et al. (2024) · Blood Advances
Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research
Cited by 21

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.